Advanced Breast Cancer Third International Consensus Conference
Disclosure of conflict of interest Faculty members have been asked to disclose any potential conflict of interest in relation to their participation in the Conference. Potential conflict of interest are considered any of the following: • Any financial interest in or arrangement with a company whose products or services are
discussed in the lecture or that might be considered as part of the consensus process. • Any financial interest in or arrangement with a competing company. • Any other financial relationship, direct or indirect, or other situations that might raise the
question of bias in the work presented or in the participation in the consensus process, including pertinent commercial or other sources of funding for the speaker or panellist or for the associated department or organisation, personal relationships or direct academic competition.
ABC3 Chairs, faculty and panel members Matti S. Aapro:
No significant relationships.
Consultant for Abraxis, Amgen, BMS, CarisLifeSciences, Celgene, Eisai, GenomicHealth, GSK, Helsinn, Hospira, Novartis, Merck, Merck Serono, Pfizer, Pierre Fabre, Roche, Sandoz, Teva, Vifor and has received honoraria for lectures at symposia f Amgen, Astellas, Bayer Schering, Cephalon, Eisai, Ferring, Genomic Health, GSK, Helsinn, Hospira, Ispen, JnJ OrthoBiotech, Merck, Merck Serono, Novartis, Pfizer, Pierre Fabre, Roche, Sandoz, Sanofi, Teva, Vifor.
Lisa A. Carey:
Fabrice André:
No significant relationships.
No significant relationships.
Giuseppe Curigliano:
Sam Aparicio:
No significant relationships.
Receipt of grants/research supports: Takeda Biopharma.
Véronique Dieras:
Carlos H. Barrios: Receipt of grants/research supports: Amgen, Astra Zeneca, Boehringer-Ingelheim, GSK, Novrtis, Pfizer, Roche/Genentech, Eisai, Lilly, Sanofi-Aventis, Celgene and has received honoraria or consultation fees from: BoehringerIngelheim, GSK, Novartis, Pfizer, Roche/Genentech.
Marc Beishon: Receipt of honorarium: Pfizer.
Jonas Bergh: Receipt of grants/research supports paid to Karolinska Institute and University Hospital: Roche, Bayer, Sanofi-Aventis, Astra Zeneca, Pfizer, Merck, Amgen.
Gouri S. Bhattacharyya: No significant relationships.
No significant relationships.
Sarbani Chaudhuri: Full time employee of Pfizer.
Robert E. Coleman: Receipt of grants/research supports: Bayer, Celgene. Expert testimony: Novartis.
Dian “CJ” M. Corneliussen-James: Receipt of honoraria for work for ABC3.
Alberto Costa:
Receipt of honoraria or consultation fees: Roche, Genentech, Novartis, Eisai. Participation in a sponsored speakers bureau: Roche, Pfizer.
Nagi S. El Saghir: Receipt of grants/research supports: GSK, Novartis, Roche. Receipt of honoraria or consultation fees: lecture honoraria: Novartis, Roche, MSD, AstraZeneca, Celgene.
Alexander Eniu: Receipt of grants/research supports: Astra Zeneca, Roche, Celltrion, Pfizer, Mylan.
Lesley Fallowfield: No significant relationships.
Doris Fenech: No significant relationships.
Patrick Flamen:
No significant relationships.
Receipt of grants/research supports: Sirtex/Bayer, receipt of honoraria or consultation fees: Sirtex/Bayer.
Fatima Cardoso:
Prudence A. Francis:
Laura Biganzoli: Receipt of honoraria or consultation fees: Astellas/medication, Astra Zeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GSK, Merck-Sharp, Merus BV, Novartis, Pfizer, Roche, Sanofi. 34
Maria João Cardoso:
ABC3 5-7 NOVEMBER 2015, LISBON, PORTUGAL
Conference travel support from Roche and Amgen.